Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea.
Eur Radiol. 2015 Jun;25(6):1561-9. doi: 10.1007/s00330-014-3568-0. Epub 2015 Jan 11.
We aimed to compare iohexol vs. diatrizoate as fecal/fluid tagging agents for computed tomography colonography (CTC) regarding examination quality.
Forty prospective patients (M:F = 23:17; 63 ± 11.6 years) received CTC using 50 mL (350 mgI/mL) oral iohexol for tagging. Forty other indication-matched, age-matched, and sex-matched patients who underwent CTC using 100 mL diatrizoate for tagging and otherwise the same technique, were retrospectively identified. Two groups were compared regarding overall examination quality, per-patient and per-segment scores of colonic bubbles (0 [no bubbles] to 5 [the largest amount]), and the volume, attenuation, and homogeneity (untagged, layered, and homogeneous) of the residual colonic fluid.
The iohexol group demonstrated a greater amount of colonic bubbles than the diatrizoate group: mean per-patient scores ± SD of 1.2 ± 0.8 vs. 0.7 ± 0.6, respectively (p = 0.003); and rates of segments showing ≥ grade 3 bubbles of 12.9 % (85/659) vs. 1.6 % (11/695), respectively (p = 0.001). Residual colonic fluid amount standardized to the colonic volume did not significantly differ: 7.2 % ± 4.2 vs. 7.8 % ± 3.7, respectively (p = 0.544). Tagged fluid attenuation was mostly comparable between groups and the fluid was homogeneously tagged in 98.7 % (224/227) vs. 99.5 % (218/219) segments, respectively (p = 0.344). Iohexol caused more colonic bubbles when used during cathartic CTC. Otherwise, examination quality was similarly adequate with both iohexol and diatrizoate.
• When used for tagging, iohexol caused significantly more colonic bubbles than diatrizoate. • The residual colonic fluid amount did not significantly differ between iohexol and diatrizoate. • The quality of fluid tagging was similarly adequate in both iohexol and diatrizoate.
我们旨在比较 iohexol 和 diatrizoate 作为粪便/液体标记物在计算机断层结肠成像(CTC)中对检查质量的影响。
40 名前瞻性患者(男:女=23:17;63±11.6 岁)接受了 CTC 检查,口服 50 毫升(350mgI/mL)iohexol 进行标记。另外,回顾性地确定了 40 名具有相同适应证、年龄和性别匹配、接受了 100 毫升 diatrizoate 进行标记的患者。比较两组的总体检查质量、结肠气泡的每位患者和每段评分(0[无气泡]至 5[最大量])以及残留结肠液体的体积、衰减和均匀性(未标记、分层和均匀)。
iohexol 组的结肠气泡量明显多于 diatrizoate 组:每位患者的平均评分±标准差分别为 1.2±0.8 与 0.7±0.6(p=0.003);显示≥3 级气泡的段数分别为 12.9%(85/659)和 1.6%(11/695)(p=0.001)。残留结肠液体量与结肠体积标准化后无显著差异:分别为 7.2%±4.2%和 7.8%±3.7%(p=0.544)。两组之间标记流体的衰减大多相当,98.7%(224/227)和 99.5%(218/219)的段标记流体均匀(p=0.344)。在使用泻剂 CTC 时,iohexol 会导致更多的结肠气泡。否则,iohexol 和 diatrizoate 的检查质量同样充足。
当用于标记时,iohexol 引起的结肠气泡明显多于 diatrizoate。
iohexol 和 diatrizoate 之间残留的结肠液体量无显著差异。
iohexol 和 diatrizoate 标记流体的质量同样充足。